1053 / 1119
Stage
I B2 / IIA
N=2
IIB
N=10
IIIB
N=12
Total
N=24
Local
--
2*
1
#
3
Pelvic Node
--
--
1
1
Dist. metastasis
--
1
1
Total
--
2
3
5
TMH Retrospective Data (Dec 2006 - May 2008) (N = 24)
Median Follow-up : 18 (12 - 40) months
* Point A: 79 Gy and HR-CTV D90 doses : 56.5, 67 Gy;
# Point A: 70 Gy and HR-CTV D90 doses : 65Gy;
Late sequelae: 1 pt with protco-sigmoiditis
(0.1 and 2cc : R 46 & 64; S: 260 & 140 Gy)
CLINICAL OUTCOME
Mahantshetty et al, Clin. Oncol. 2011 ; IJGC Aug. 2011